BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26194715)

  • 1. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?
    Gates VL; Hickey R; Marshall K; Williams M; Salzig K; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2038-44. PubMed ID: 26194715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies.
    Sun B; Lapetino SR; Diffalha SA; Yong S; Gaba RC; Bui JT; Koppe S; Garzon S; Guzman G
    Hum Pathol; 2016 Apr; 50():11-4. PubMed ID: 26997433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
    Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
    J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients.
    Peterson JL; Vallow LA; Johnson DW; Heckman MG; Diehl NN; Smith AA; Tzou KS; Paz-Fumagalli R; Kim S; Ko SJ; Daugherty LC; Kim GP; Brown N; Mori KW; Buskirk SJ
    Brachytherapy; 2013; 12(6):573-9. PubMed ID: 23953810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
    Konda A; Savin MA; Cappell MS; Duffy MC
    Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model.
    Pasciak AS; Nodit L; Bourgeois AC; Paxton BE; Coan PN; Clark CT; Tolbert MK; Adams JK; Arepally A; Bradley YC
    J Nucl Med; 2016 Dec; 57(12):1957-1963. PubMed ID: 27390155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors.
    Rodríguez-Lago I; Carretero C; Herráiz M; Subtil JC; Betés M; Rodríguez-Fraile M; Sola JJ; Bilbao JI; Muñoz-Navas M; Sangro B
    World J Gastroenterol; 2013 May; 19(19):2935-40. PubMed ID: 23704826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature.
    Naymagon S; Warner RR; Patel K; Harpaz N; Machac J; Weintraub JL; Kim MK
    Dig Dis Sci; 2010 Sep; 55(9):2450-8. PubMed ID: 20198431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial radioembolization of breast cancer liver metastases: a structured review.
    Smits ML; Prince JF; Rosenbaum CE; van den Hoven AF; Nijsen JF; Zonnenberg BA; Seinstra BA; Lam MG; van den Bosch MA
    Eur J Pharmacol; 2013 Jun; 709(1-3):37-42. PubMed ID: 23545356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1617-1623. PubMed ID: 28132407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
    Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.
    Hickey R; Lewandowski RJ; Prudhomme T; Ehrenwald E; Baigorri B; Critchfield J; Kallini J; Gabr A; Gorodetski B; Geschwind JF; Abbott A; Shridhar R; White SB; Rilling WS; Boyer B; Kauffman S; Kwan S; Padia SA; Gates VL; Mulcahy M; Kircher S; Nimeiri H; Benson AB; Salem R
    J Nucl Med; 2016 May; 57(5):665-71. PubMed ID: 26635340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?
    McCann JW; Larkin AM; Martino LJ; Eschelman DJ; Gonsalves CF; Brown DB
    J Vasc Interv Radiol; 2012 May; 23(5):661-7. PubMed ID: 22440592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
    Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
    J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres.
    Yim SY; Kim JD; Jung JY; Kim CH; Seo YS; Yim HJ; Um SH; Ryu HS; Kim YH; Kim CS; Shin E
    Clin Mol Hepatol; 2014 Sep; 20(3):300-5. PubMed ID: 25320734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.
    Kuo JC; Tazbirkova A; Allen R; Kosmider S; Gibbs P; Yip D
    Asia Pac J Clin Oncol; 2014 Sep; 10(3):266-72. PubMed ID: 25135200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.